Myocardial uptake of iodine-125-labeled 15-(P-Iodophenyl)-3-(R,S)- methyl pentadecanoic acid is decreased in chronic diabetic rats with changes in subcellular distribution

Japanese Circulation Journal

Volumn 62, Issue 5, 1998, Pages 364-370

  Shinmura, Ken ^a   Tani, Masato ^a   Suganuma, Yukako ^a   Hasegawa, Hiroshi ^a   Hayashi, Yoko ^a   Guo, Xing Dong ^a   Nakamura, Yoshiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Fatty acid metabolism; Iodine 125 1abeled 15 (p iodophenyl) 3 (R,S) methyl pentadecanoic acid (125I BMIPP); Mitochondria; Myocardium

Indexed keywords

15 (4 IODOPHENYL)PENTADECANOIC ACID; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; FATTY ACID METABOLISM; HEART MUSCLE METABOLISM; ISOTOPE LABELING; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; HYPOGLYCEMIC AGENTS; INSULIN; IODINE RADIOISOTOPES; IODOBENZENES; LIPID METABOLISM; LIPIDS; MALE; MITOCHONDRIA; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

EID: 0031978911     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.364     Document Type: Article

References (47)

1. Opie LH: Fuels. Carbohydrates and lipitis. In: Opie LH, editor. The heart. Physiology and metabolism, 2nd edn. New York: Raven Press, 1991: 208-246
2. 123I-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy. J Nucl Med Allied Sci 1983; 27: 267-279
3. Kennedy PL, Corbett JR, Kulkarni PV, Wolfe CL, Jansen DE, Hansen CL, et al: Iodine-123-phenylpentadecanoic acid myocardial scintigraphy usefulness in the identification of myocardial ischemia. Circulation 1986; 74: 1007-1015
4. Visser FC, Van Eenige MJ, Duwel CMB, Van Lingen A, Roos JP: Radioiodinated fatty acid scintigraphy of the normal human myocardium during exercise testing: a new interpretation. NucCompact 1990; 21: 236-240
5. Kuikka JT, Mustonen JN, Uusitupa MIJ, Rautio P, Vanninen E, Laakso E, et al: Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin-dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid. Eur J Nucl Med 1991; 18: 475-481
6. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al: Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nacl Med 1992; 33: 659-667
7. Knapp Jr. FR, Franken P, Kropp J: Cardiac SPECT with iodine123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022-1030
8. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, et al: Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13
9. 123I-beta-methyl-iodophenyl-pentadecanoic acid myocardial scintigraphy in diabetic patients without overt ischemic heart disease (in Japanese, abstract in English). J Cardiol 1995; 26: 23-32
10. Tawarahara K, Kurata C, Taguchi T, Aoshima S, Okayama K, Kobayashi A, et al: Simultaneous dual myocardial imaging with iodine-123-beta-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease. Jpn Circ J 1994; 58: 107-115
11. Knapp Jr. FF, Ambrose KR, Goodman MM: New radioiodinated methyl-branched fatty acid for cardiac studies. Eur J Nucl Med 1986; 12: S39-S44
12. Ambrose KR, Owen BA, Goodman MM, Knapp Jr FK: Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987; 12: 486-491
13. Dormehl IC, Hugo N, Rossouw D, White A, Feinendegen LE: Planar myocardial imaging in the baboon model with iodine-123-15-(iodophenyl) pentadenanoic acid (IPPA) and iodine-123-15-(p-iodophenyl)-3-R,S-methylpentadenanoic acid (BMIPP), using time - activity curves for evaluation of metabolism. Nucl Med Biol 1995; 22: 837-847
14. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Tamaki N, Konishi J, et al: Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37: 757 -761
15. 123I-BMIPP). Eur J Nucl Med 1996; 23: 383-389
16. McDaniel HG, Jenkins RL, Digerness SB: Myocardial fuel and energy balance, acute ischemia and diabetes. Am J Med Sci 1988: 295: 207-211
17. Dhalla NS, Elimban V, Rupp H: Paradoxical role of lipid metabolism in heart function and dysfunction. Mol Cell Biochem 1992; 116: 3-9
18. Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mal Cell Cardiol 1995; 27: 169-179
19. Zarich SW, Nesto RW: Diabetic cardiomyopathy. Am Heart J 1989; 118: 1000-1012
20. Bell DSH: Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care 1995; 18: 708-714
21. Folch J, Lees M, Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509
22. Christe ME, Rodgers RL: Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension 1995; 25: 235-241
23. Van der Wall EE, Barrett E, Straus HW, Lange R, Elmaleh D, Zaret BL, et al: Altered uptake and kinetics of radioiodinated 15-p-(I-125)-iodophenyl-3-methylpentadecanoic acid in diabetic myocardium (abstract). Circulation 1985; 72: III-424
24. Lopaschuk GD, Tsang H: Metabolism of palmitate in isolated working hearts from spontaneously diabetic "BB" wistar rats. Circ Res 1987; 61: 853-858
25. Paulson DJ, Shug AL, Jurak R, Schmidt: The role of altered lipid metabolism in the cardiac dysfunction associated with diabetes. In: Nagano M, Dhalla NS, editors. The diabetic heart. New York: Raven Press, 1991: 395-407
26. Lopaschuk GD, Spafford MA: Glucose and palmitate oxidation during reperfusion of ischemic hearts from diabetic rats. In: Nagano M, Dhalla NS, editors. The diabetic heart. New York: Raven Press, 1991: 451-464
27. Vyska K, Meyer W, Stremmel W, Notohamiprodjo G, Minami K, Machulla HJ, et al: Fatty acid uptake in normal human myocardium. Circ Res 1991; 69: 857-870
28. Schulz H: Beta-oxidation of fatty acids. Biochim Biophys Acta 1991; 1081: 109-120
29. Glatz JFC, Van Breda E, Keizer HA, De Jong YF, Lakey JRT, Rajotte RV, et al: Rat heart fatty acid-binding protein content is increased in experimental diabetes. Biochem Biophys Res Commun 1994; 199: 639-646
30. Murase T, Mochizuki S, Yamaoka H, Nagano M: Lipoprotein lipase activity in isolated perfused hearts of streptozotocin-induced diabetic rats. In: Nagano M, Dhalla NS, editors. The diabetic heart. New York: Raven Press, 1991: 409-413
31. 125I-BMIPP in rats treated with adriamycin (in Japanese, Abstract in English). Jpn J Nucl Med 1989; 26: 69-76
32. Tanaka Y, Konno N, Kako KJ: Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc Res 1992; 26: 409-414
33. Pierce GN, Dhalla NS: Mitochondrial abnormalities in diabetic cardiomyopathy. Can J Cardiol 1985; 1: 48 -55
34. Kuo TH, Giacomelli F, Wiener J: Oxidative metabolism of Polytron vs Nagarse mitochondria in hearts of genetically diabetic mice. Biochim Biophys Acta 1985; 806: 9-15
35. Forsey RG, Reid K, Brosnan JT: Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart. Can J Physiol Pharmacol 1987; 65: 401-406
36. Paulson DJ, Crass MF III: Endogenous triacylglycerol metabolism in diabetic heart. Am J Physiol 1982; 142: H1084-H1094
37. Griffiths EJ, Lloyd AJ, Brunt RV: Effect of ischemia and reperfusion on lipid metabolism and glycogenolysis in hearts from normal and diabetic rats. In: Nagano M, Dhalla NS, editors. The diabetic heart. New York: Raven Press, 1991: 441 -449
38. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al: Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822
39. Awan MM, Saggerson ED: Malonyl-CoA metabolism in cardiac myocyte and its relevance to the control of fatty acid oxidation. Biochem J 1993; 295: 61 -66
40. Lopaschuk GD, Gamble J: Acetyl-CoA carboxylase. An important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol 1994; 72: 1101-1109
41. Fogle PJ, Beiber LL: Effect of streptozotocin on carnitine and carnitine acyl transferase in rat heart, liver, kidney. Biochem Med 1979; 22: 119-126
42. Aoshima S, Fujisawa S, Kobayashi A: Changes in the subcellular distribution of free carnitine and its acyl derivatives in diabetic rat hearts following treatment with L-carnitine. Jpn Heart J 1993; 34: 763-772
43. Vary TC, Neely JR: A mechanism of reduced myocardiai carnitine levels in diabetic animals. Am J Physiol 1982; 243: H154-H158
44. Reddi AS, Jyothirmayi GN, DeAngelis B, Frank O, Baker H: Effect of short- and long-term diabetes on carnitine and myo-inositol in rats. Comp Biochem Physiol 1991; 98A: 39-42
45. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H: Fundamental limitations of (18F)2-deoxy-2-fluoro-D-glucose for assessing myocardiai glucose uptake. Circulation 1995; 91: 2435-2444
46. Thompson EW: Quantitative analysis of myocardiai structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soe Exp Biol Med 1994; 205: 294-305
47. Miller DD, Gill JB, Livni E, Elmaleh DR, Aretz T, Boucher CA, et al: Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988; 63: 681-692